Wegovy Injection Dosing Schedule: Increase Your Dose Safely for Weight Loss

Wegovy follows a gradual 16-week dose escalation schedule, with the weekly semaglutide dose typically increased every four weeks to improve tolerability and reduce side effects.

Wegovy Injection Dosing Schedule: Increase Your Dose Safely for Weight Loss

A Wegovy injection is usually started at a low dose and increased gradually to help your body adjust to semaglutide. Treatment typically begins at 0.25 mg once weekly, with the dose increased every four weeks when appropriate, helping to reduce the likelihood of gastrointestinal side effects.

The Wegovy dosing schedule progresses through 0.5 mg, 1 mg and 1.7 mg before reaching the recommended 2.4 mg weekly maintenance dose. Dose increases should follow your prescriber’s guidance, and escalation may be delayed if side effects are difficult to tolerate. But what happens at each stage, and when might your dose need to stay lower for longer?

GLP-1

Wegovy

A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
  • ✔ ~16.9% average body weight loss
  • ✔ Boosts metabolic & cardiovascular health
  • ✔ Proven, long-established safety profile
  • ✔ Weekly injection, easy to use

Key Takeaways: Wegovy Injection Dosing Schedule

  • Wegovy starts at 0.25 mg weekly and increases gradually to improve treatment tolerability.
  • The standard dose progression moves through 0.5 mg, 1 mg and 1.7 mg before reaching 2.4 mg.
  • Temporary digestive effects can become more noticeable after each dose increase.
  • Missed doses should be managed according to timing rather than replaced with an extra dose.
  • Correct injection technique, site rotation and regular clinical review help support safe ongoing treatment.

How Does the Wegovy Shot Work for Weight Loss?

A Wegovy injection contains semaglutide, which acts like the natural GLP-1 hormone involved in appetite regulation. It helps you feel fuller, reduces hunger and can lower calorie intake, supporting weight loss alongside a reduced-calorie diet and increased physical activity. Treatment starts at a low strength and increases gradually to improve tolerability.

Month 1: Weeks 1 to 4 (0.25 mg Dose)

Treatment usually begins with 0.25 mg once weekly for four weeks. This is the starting dose rather than a maintenance dose, allowing your body to become accustomed to semaglutide. Some people may notice reduced hunger or earlier fullness, while nausea, diarrhoea, constipation, vomiting or abdominal discomfort can occur during the adjustment period.

Month 2: Weeks 5 to 8 (0.5 mg Dose)

From week 5, the usual weekly dose increases to 0.5 mg if treatment is being tolerated appropriately. Appetite control may become more noticeable as semaglutide continues to increase feelings of fullness and reduce food intake. Digestive side effects can temporarily become more noticeable following a dose increase, although individual experiences and weight changes vary.

Month 3: Weeks 9 to 12 (1 mg Dose)

The next stage of the Wegovy dose schedule usually increases treatment to 1 mg once weekly from week 9. At this stage, some people experience more consistent appetite control and find smaller portions more satisfying. Weight loss may continue progressively when treatment is combined with appropriate dietary changes and physical activity, but results differ between individuals.

Month 4: Weeks 13 to 16 (1.7 mg Dose)

From week 13, the usual dose increases to 1.7 mg once weekly, provided the previous strength has been tolerated. The gradual increase in Wegovy injection doses is designed to reduce the likelihood of troublesome gastrointestinal symptoms while moving towards maintenance treatment. If significant gastrointestinal symptoms occur, dose escalation may need to be delayed following clinical assessment.

Month 5 and Beyond: Week 17+ (2.4 mg Maintenance Dose)

From week 17, the recommended maintenance dose is usually 2.4 mg once weekly. Semaglutide continues to support appetite regulation and reduced energy intake, while longer-term weight loss depends on treatment response, adherence, diet and physical activity. Your prescriber should review tolerability and progress, particularly if side effects develop or the standard dose progression cannot be followed.

Your response to treatment should be considered before moving to a higher strength. A Wegovy online consultation allows a qualified clinician to assess your current dose, treatment progress and side effects before deciding whether a dose increase is appropriate.

What Is the Wegovy Injection Dosing Schedule?

The dosing schedule for Wegovy weight loss injections is designed to be gradual and carefully supervised. Treatment begins at a low dose and increases in stages to improve tolerance and reduce unwanted effects. Each step allows the body time to adjust before progressing further. Dose changes should only take place under clinical guidance.

Weeks 1–4: Wegovy 0.25 mg Once Weekly

This is the initial starting dose and is taken once weekly. It is not intended as a long-term treatment dose but helps the body adapt safely. During these first weeks, some people may notice mild nausea or digestive discomfort. These effects are usually temporary as the system adjusts.

Weeks 5–8: Wegovy 0.5 mg Once Weekly

If the starting dose is well tolerated, the strength increases to 0.5 mg once weekly. Appetite control may become more noticeable during this period. Gradual escalation supports safety and improves overall tolerability. Ongoing monitoring helps determine whether it is appropriate to move to the next stage.

Weeks 9–12: Wegovy 1 mg Once Weekly

At this stage, the weekly dose increases to 1 mg. Many individuals begin to see steadier changes in portion control and hunger levels. Digestive symptoms often settle as the body becomes accustomed to treatment. Clinical review remains important before further escalation.

Weeks 13–16: Wegovy 1.7 mg Once Weekly

The Wegovy 1.7 mg dose serves as a transition level before reaching the full maintenance strength. Some patients may remain on this dose for longer if higher strengths are not well tolerated. The aim is steady progression rather than rapid increase. Safety and individual response guide the timing of any adjustment.

Week 17 Onwards: Wegovy 2.4 mg Maintenance Dose

The usual maintenance dose is Wegovy 2.4 mg, taken once weekly. This is the strength associated with sustained weight management when combined with lifestyle measures. Not everyone reaches the 2.4 mg maintenance dose. If higher strengths are not well tolerated, your healthcare professional may recommend continuing on a lower dose until it is appropriate to increase treatment.

Dose increases are not automatic. If side effects occur, clinicians may pause or keep you on a lower dose after review, including via an online consultation in the UK. Ongoing supervision helps keep Wegovy weight loss injections safe and appropriate.

What to Expect When Increasing Your Wegovy Dose

Each step in the Wegovy dosing schedule is designed to help your body adjust gradually to a higher dose. As you progress through treatment, you may notice stronger appetite control alongside temporary digestive side effects. These changes are a normal part of Wegovy dose titration and often improve within a few weeks.

Temporary Digestive Side Effects

As your dose increases, you may experience mild digestive symptoms while your body adapts. These are usually temporary and are most noticeable during the first few days after a Wegovy weekly injection.

  • Nausea or vomiting: The most common side effects, which often improve within 2 to 4 weeks.
  • Constipation or diarrhoea: Changes in bowel habits may occur as digestion slows.
  • Bloating or indigestion: Feeling overly full or mild stomach discomfort is common, particularly after meals.

Changes in Appetite and Weight

As you move through the Wegovy dosing for weight loss plan, you may notice changes in your appetite and eating habits.

  • Reduced food cravings: Thoughts about food may become less frequent.
  • Earlier fullness: You may feel satisfied after eating smaller portions because Wegovy slows stomach emptying and increases feelings of fullness.

If side effects become severe or do not improve, speak to your healthcare professional before making any changes to your Wegovy dosing schedule. Dose increases should always follow clinical guidance and should never be adjusted without medical advice.

Who Is Eligible to Start Wegovy Treatment?

Before Wegovy is prescribed, a full medical assessment is carried out to confirm suitability. In the UK, treatment is generally considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition, following a clinical assessment. Existing health conditions, current medications, and medical history are also reviewed to ensure Wegovy is appropriate and safe.

You can check if you are eligible to use Wegovy before beginning treatment. Confirming eligibility helps ensure the medication is prescribed in line with clinical guidance and that appropriate follow-up and ongoing monitoring can be arranged throughout your treatment.

Why Do Gradual Dose Increases Matter?

The gradual dose escalation used in the STEP clinical trials was designed to improve treatment tolerability while reducing the risk of gastrointestinal side effects. This evidence-based approach allows the body to adjust safely before progressing to the next dose.

  1. It reduces the intensity of common gastrointestinal side effects.
  2. It improves long-term adherence to treatment.

Moving too quickly can increase nausea, vomiting or diarrhoea. The gradual approach ensures the Wegovy shot remains manageable and sustainable.

If you miss a dose or are unsure about timing, seek professional guidance before adjusting your schedule. Self-directed changes are not recommended.

What Happens If You Miss a Dose?

If you miss Wegovy for weight loss treatment the action you should take depends on how much time has passed since your scheduled injection. Take the missed dose within 5 days where possible. If more than 5 days have passed, skip it and take your next dose on the usual scheduled day.

What Happens in Your Body

  • Semaglutide has a half-life of around one week so the amount in your body decreases gradually rather than disappearing immediately.
  • Missing a single injection does not completely remove semaglutide from your system because the medicine remains in circulation for several weeks.
  • The appetite-regulating effect may become less consistent as semaglutide levels gradually fall although individual responses can vary.
  • If you miss several injections your Wegovy dosing may need to be reviewed before restarting treatment to help reduce gastrointestinal side effects.

How Should You Inject Wegovy Correctly?

Using the correct technique is important for both safety and effectiveness. Wegovy is given as a once-weekly injection under the skin, and careful site selection helps reduce irritation. Always follow the instructions provided with your prescription and ensure the dose is administered exactly as directed.

Choosing the Injection Area

Wegovy is injected into the fatty layer beneath the skin. Suitable areas include the abdomen, upper arm or thigh. Many people find injecting into the thigh or abdomen more comfortable and easier to manage. The chosen Wegovy injection site should be clean, dry and free from cuts or irritation before use.

Rotating Injection Sites

It is important not to use the exact same spot each week. Rotate within the same general area by moving slightly away from the previous injection point. This helps reduce redness, swelling and skin sensitivity. Never inject into bruised, inflamed or damaged skin.

Using the Pen and Needle Safely

Each dose is delivered through a pre-filled pen containing a fine Wegovy needle. The needle is designed for single use and should not be reused. After completing the injection, dispose of the pen safely as advised by your healthcare provider. Proper handling reduces the risk of infection and ensures accurate dosing.

How Can You Access Wegovy in the UK?

Wegovy is supplied through regulated prescribing services following a structured medical assessment. An online consultation may be used to determine whether treatment is suitable based on your health history and weight-related criteria. This ensures the medicine is provided safely and in line with responsible prescribing standards.

If approved, patients receive clear guidance on how to use the medication and arrange follow-up care. To understand the correct process, you can review how to buy Wegovy pen safely in the UK.

A legitimate Wegovy online prescription always includes proper screening, medical review and ongoing monitoring to support safe and effective treatment.

Conclusion: Staying Safe While Using Wegovy

A Wegovy injection works best when treatment follows the recommended gradual dose escalation and is supported by appropriate clinical monitoring. Starting at 0.25 mg once weekly gives the body time to adjust before progressing through the higher strengths towards the maintenance dose.

Your response and tolerability should guide treatment alongside advice from your prescriber. Do not increase the dose yourself or take extra medicine after a missed dose. If side effects become difficult to manage or several doses are missed, seek clinical advice before continuing or changing your treatment.

GLP-1 / GIP

Mounjaro

Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
  • ✔ ~22.5% average body weight loss
  • ✔ Significant weight reduction
  • ✔ Improves blood sugar levels
  • ✔ Clinically proven weight loss
GLP-1

Wegovy

A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
  • ✔ ~16.9% average body weight loss
  • ✔ Boosts metabolic & cardiovascular health
  • ✔ Proven, long-established safety profile
  • ✔ Weekly injection, easy to use

FAQs

The usual starting dose is 0.25 mg once weekly for the first four weeks. The Wegovy dose schedule then increases gradually at four-week intervals when treatment is tolerated, rather than beginning with a higher maintenance strength.

The standard Wegovy injection doses used during dose escalation are 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg. Treatment usually progresses through these strengths gradually to improve gastrointestinal tolerability.

Wegovy is administered once a week, preferably on the same day each week. Your Wegovy weekly injection can be given at any time of day and does not need to be taken with meals.

No. Wegovy dosing should follow the prescribed escalation plan and should not be increased without clinical guidance. Moving to a higher strength too quickly may increase the likelihood of gastrointestinal side effects such as nausea, vomiting and diarrhoea.

If the missed dose is within 5 days, take it as soon as possible. If more than 5 days have passed, skip the missed dose and take your next injection on the usual scheduled day. Never take an extra dose to compensate for one you have missed.

Dose escalation may need to be delayed if gastrointestinal symptoms are significant. Your prescriber can assess your side effects and treatment response before deciding when it is appropriate to progress to the next strength.

Wegovy is injected under the skin of the abdomen, thigh or upper arm. Injection sites should be rotated rather than using exactly the same spot each week, and the medicine should not be injected into damaged, tender or irritated skin.

Speak to your prescriber if side effects are persistent, severe or difficult to tolerate, particularly after increasing the dose. Seek urgent medical attention for symptoms that could indicate a serious reaction, such as severe and persistent abdominal pain or signs of a severe allergic reaction.

Start Online Consultation

Your First Step Towards Safer Weight Loss Starts Here

VIEW ALL TREATMENTS